Regentis Biomaterials
RGNT
#10651
Rank
$14.25 M
Marketcap
$2.03
Share price
-2.86%
Change (1 day)
N/A
Change (1 year)
Categories

Revenue for Regentis Biomaterials (RGNT)

Revenue in 2025: N/A

In 2025 the company made a revenue of N/A a decrease over the revenue in the year 2024 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Regentis Biomaterials from 2020 to 2025

Annual revenue

Year Revenue Change
2025N/A
2024N/A
2023N/A
2022N/A
2021N/A
2020N/A